Gut Hormones as Mediators of Appetite and Weight Loss After Roux-en-Y Gastric Bypass

Annals of Surgery - Tập 246 Số 5 - Trang 780-785 - 2007
Carel W. le Roux1, Richard Welbourn2, Malin Werling3, Alan Osborne2, Alexander Kokkinos1, Anna Laurenius3, Hans Lönroth3, Lars Fändriks3, Mohammad A. Ghatei1, Stephen R. Bloom1, Torsten Olbers3
1Department of Metabolic Medicine, Hammersmith Hospital, Imperial College, London, United Kingdom
2Department of Surgery, Musgrove Park Hospital, Taunton, United Kingdom
3VO Kirurgi/Enh f Gastrokir forskn, SU/Sahlgrenska, Göteborg, Sweden.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Le Roux, 2006, Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters., Ann Surg, 243, 108, 10.1097/01.sla.0000183349.16877.84

Sjostrom, 2004, Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery., N Engl J Med, 351, 2683, 10.1056/NEJMoa035622

Pories, 1995, Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus., Ann Surg, 222, 339, 10.1097/00000658-199509000-00011

Adrian, 1985, Human distribution and release of a putative new gut hormone, peptide YY., Gastroenterology, 89, 1070, 10.1016/0016-5085(85)90211-2

Adrian, 1987, Release of peptide YY (PYY) after resection of small bowel, colon, or pancreas in man., Surgery, 101, 715

Adrian, 1986, Peptide YY abnormalities in gastrointestinal diseases., Gastroenterology, 90, 379, 10.1016/0016-5085(86)90936-4

Batterham, 2003, Inhibition of food intake in obese subjects by peptide YY3-36., N Engl J Med, 349, 941, 10.1056/NEJMoa030204

Batterham, 2002, Gut hormone PYY(3–36) physiologically inhibits food intake., Nature, 418, 650, 10.1038/nature00887

Halatchev, 2004, Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism., Endocrinology, 145, 2585, 10.1210/en.2003-1754

Challis, 2004, Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY3-36., Proc Natl Acad Sci U S A, 101, 4695, 10.1073/pnas.0306931101

Cox, 2004, Enhancement of feeding suppression by PYY(3–36) in rats with area postrema ablations., Peptides, 25, 985, 10.1016/j.peptides.2004.03.003

Riediger, 2004, Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression., Neuroendocrinology, 79, 317, 10.1159/000079842

Pittner, 2004, Effects of PYY[3–36] in rodent models of diabetes and obesity., Int J Obes Relat Metab Disord, 28, 963, 10.1038/sj.ijo.0802696

Chelikani, 2005, Intravenous infusion of peptide YY(3–36) potently inhibits food intake in rats., Endocrinology, 146, 879, 10.1210/en.2004-1138

Kreymann, 1987, Glucagon-like peptide-1 7–36: a physiological incretin in man., Lancet, 2, 1300, 10.1016/S0140-6736(87)91194-9

Naslund, 1999, Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men., Int J Obes Relat Metab Disord, 23, 304, 10.1038/sj.ijo.0800818

Wren, 2001, Ghrelin enhances appetite and increases food intake in humans., J Clin Endocrinol Metab, 86, 5992, 10.1210/jcem.86.12.8111

Naslund, 1997, Reduced food intake after jejunoileal bypass: a possible association with prolonged gastric emptying and altered gut hormone patterns., Am J Clin Nutr, 66, 26, 10.1093/ajcn/66.1.26

Kenler, 1990, Changes in eating behavior after horizontal gastroplasty and Roux-en-Y gastric bypass., Am J Clin Nutr, 52, 87, 10.1093/ajcn/52.1.87

Delgado-Aros, 2004, Independent influences of body mass and gastric volumes on satiation in humans., Gastroenterology, 126, 432, 10.1053/j.gastro.2003.11.007

Le Roux, 2006, Attenuated peptide YY release in obese subjects is associated with reduced satiety., Endocrinology, 147, 3, 10.1210/en.2005-0972

Christou, 2006, Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years., Ann Surg, 244, 734, 10.1097/01.sla.0000217592.04061.d5

Higa, 2001, Laparoscopic Roux-en-Y gastric bypass: technique and 3-year follow-up., J Laparoendosc Adv Surg Tech A, 11, 377, 10.1089/10926420152761905

McCarty, 2005, Optimizing outcomes in bariatric surgery: outpatient laparoscopic gastric bypass., Ann Surg, 242, 494, 10.1097/01.sla.0000183354.66073.4c

Kehlet, 2003, Anaesthesia, surgery, and challenges in postoperative recovery., Lancet, 362, 1921, 10.1016/S0140-6736(03)14966-5

Savage, 1987, Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers., Gut, 28, 166, 10.1136/gut.28.2.166

Adrian, 1976, Distribution and release of human pancreatic polypeptide., Gut, 17, 940, 10.1136/gut.17.12.940

Patterson, 2005, Characterization of ghrelin-like immunoreactivity in human plasma., J Clin Endocrinol Metab, 90, 2205, 10.1210/jc.2004-1641

Borg, 2006, Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety., Br J Surg, 93, 210, 10.1002/bjs.5227

Dixon, 2005, Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study., J Clin Endocrinol Metab, 90, 813, 10.1210/jc.2004-1546

Neary, 2005, Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively., Endocrinology, 146, 5120, 10.1210/en.2005-0237